GLP-1 receptor agonists, CKD, and eGFR trajectory - Authors' reply.

Authors

Katherine R Tuttle, Providence Health Care, University of Washington, Spokane, WA 99204, USAFollow
Mark C Lakshmanan
Brian Rayner
Robert S Busch
Alan G Zimmermann
D Bradley Woodward
Fady T Botros

Document Type

Article

Publication Date

10-1-2018

Clinical Institute

Kidney & Diabetes

Department

Nephrology

Recommended Citation

Tuttle, Katherine R; Lakshmanan, Mark C; Rayner, Brian; Busch, Robert S; Zimmermann, Alan G; Woodward, D Bradley; and Botros, Fady T, "GLP-1 receptor agonists, CKD, and eGFR trajectory - Authors' reply." (2018). Articles, Abstracts, and Reports. 836.
https://digitalcommons.providence.org/publications/836